Similar Papers

Paper Title
Journal
Date
Author
Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non–small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)
Nasser Altorki ... Thomas E Stinchcombe
The Journal of thoracic and cardiovascular surgery | VOL. 167
Nasser Altorki, et. al.Nasser Altorki ... Thomas E Stinchcombe
18 Jul 2023
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)
...
The Lancet Respiratory Medicine | VOL. 6
, et. al. ...
12 Nov 2018
Oncological Outcomes of Lobar Resection, Segmentectomy, and Wedge Resection for T1a Non–Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
Michiel A Ijsseldijk ... Richard P.G Ten Broek
Seminars in Thoracic and Cardiovascular Surgery | VOL. 32
Michiel A Ijsseldijk, et. al.Michiel A Ijsseldijk ... Richard P.G Ten Broek
09 Aug 2019
Comparison of survivals between sublobar resection and lobar resection for patients with clinical stage I non-small cell lung cancer and interstitial lung disease: a propensity score matching analysis.
Ryohei Matsushima ... Hiroyuki Yamada
Thoracic cancer | VOL. 15
Ryohei Matsushima, et. al.Ryohei Matsushima ... Hiroyuki Yamada
09 Sep 2024
View more papers

More From: JTO Clinical and Research Reports

Paper Title
Journal
Date
Author
Temporal trends in the utilization and survival outcomes of lobar, segmental, and wedge resection for early-stage NSCLC, 2004-2020
Eden Z Deng ... Nasser Altorki
JTO Clinical and Research Reports | VOL. -
Eden Z Deng, et. al.Eden Z Deng ... Nasser Altorki
01 Jan 2025
Impact of immune checkpoint inhibitors and local radical treatment on survival outcomes in synchronous oligometastatic NSCLC
Mandy Jongbloed ... Lizza E.L Hendriks
JTO Clinical and Research Reports | VOL. -
Mandy Jongbloed, et. al.Mandy Jongbloed ... Lizza E.L Hendriks
01 Jan 2025
Tocilizumab for Steroid Pulse-Refractory Cytokine Release Syndrome in Chemotherapy With Durvalumab Plus Tremelimumab for Non-Small Cell Lung Cancer: A Case Report
Ken Yamamoto ... Akito Hata
JTO Clinical and Research Reports | VOL. -
Ken Yamamoto, et. al.Ken Yamamoto ... Akito Hata
01 Jan 2025
Mucocutaneous Adverse Events in Cancer Patients Treated with Selective RET Kinase Inhibition
Rachel E Reingold ... Alexander Drilon
JTO Clinical and Research Reports | VOL. -
Rachel E Reingold, et. al.Rachel E Reingold ... Alexander Drilon
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.